FFA
BSX icon

Fairfield Financial Advisors’s Boston Scientific BSX Stock Holding History

Fairfield Financial Advisors’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-5,266
Closed -$330K – 67
2026
Q1 		$330K Sell
5,266
-100
-2% -$8K 0.11% 64
2025
Q4 		$512K Buy
5,366
+150
+3% +$14.7K 0.17% 55
2025
Q3 		$509K Buy
5,216
+2,575
+98% +$267K 0.17% 54
2025
Q2 		$284K Buy
2,641
+45
+2% +$4.55K 0.1% 66
2025
Q1 		$262K Buy
2,596
+1,996
+333% +$201K 0.1% 64
2024
Q4 		$53.6K Buy
+600
New +$52.8K 0.02% 110

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Fairfield Financial Advisors's BSX Position: Q2 2026 in Review

Fairfield Financial Advisors sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 5,266 shares — an estimated $330K sold.

Fairfield Financial Advisors first reported a position in BSX in Q4 2024 and held it in 6 quarters. The position peaked at $512K in Q4 2025. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Fairfield Financial Advisors reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
  • Fairfield Financial Advisors sold 5,266 Boston Scientific shares in Q2 2026, an estimated $330K.
  • Fairfield Financial Advisors first reported a position in Boston Scientific in Q4 2024 and held it in 6 quarters.
  • Fairfield Financial Advisors's Boston Scientific position peaked at $512K in Q4 2025.
  • 1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Fairfield Financial Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.